DMTF1 and non-small cell lung carcinoma: When we conducted quadruple analysis of NSCLC for Cyclin D1 and hDMP1 LOH, we found significantly shorter survival for the group without Cyclin D1 expression without LOH for hDMP1 (p = 0.0031, χ2 = 13.8559 for PFS; p = 0.0020, χ2 = 14.8269 for TS; Figure 3C,D).